SEC Form 4 · accession 0001127602-19-008332
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 25, 2019
Accepted (ET)
Feb 26, 2019 · 3:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | S | 100 | $144.43 | D | 321,552 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.44 | D | 321,352 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.46 | D | 321,152 | D | |
| Common Stock | Feb 25, 2019 | S | 800 | $144.47 | D | 320,352 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.475 | D | 320,252 | D | |
| Common Stock | Feb 25, 2019 | S | 106 | $144.48 | D | 320,146 | D | |
| Common Stock | Feb 25, 2019 | S | 155 | $144.485 | D | 319,991 | D | |
| Common Stock | Feb 25, 2019 | S | 411 | $144.49 | D | 319,580 | D | |
| Common Stock | Feb 25, 2019 | S | 570 | $144.50 | D | 319,010 | D | |
| Common Stock | Feb 25, 2019 | S | 110 | $144.505 | D | 318,900 | D | |
| Common Stock | Feb 25, 2019 | S | 738 | $144.51 | D | 318,162 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $144.52 | D | 317,762 | D | |
| Common Stock | Feb 25, 2019 | S | 500 | $144.53 | D | 317,262 | D | |
| Common Stock | Feb 25, 2019 | S | 25 | $144.535 | D | 317,237 | D | |
| Common Stock | Feb 25, 2019 | S | 591 | $144.54 | D | 316,646 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.55 | D | 316,546 | D | |
| Common Stock | Feb 25, 2019 | S | 700 | $144.56 | D | 315,846 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.565 | D | 315,746 | D | |
| Common Stock | Feb 25, 2019 | S | 804 | $144.57 | D | 314,942 | D | |
| Common Stock | Feb 25, 2019 | S | 313 | $144.58 | D | 314,629 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.59 | D | 314,529 | D | |
| Common Stock | Feb 25, 2019 | S | 662 | $144.595 | D | 313,867 | D | |
| Common Stock | Feb 25, 2019 | S | 500 | $144.60 | D | 313,367 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.